AU2543301A - Method and kit for diagnosis of neoplastic transformation - Google Patents

Method and kit for diagnosis of neoplastic transformation

Info

Publication number
AU2543301A
AU2543301A AU25433/01A AU2543301A AU2543301A AU 2543301 A AU2543301 A AU 2543301A AU 25433/01 A AU25433/01 A AU 25433/01A AU 2543301 A AU2543301 A AU 2543301A AU 2543301 A AU2543301 A AU 2543301A
Authority
AU
Australia
Prior art keywords
diagnosis
kit
neoplastic transformation
neoplastic
transformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25433/01A
Inventor
Linda A. Kowalski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vera Genics Ltd
Original Assignee
Vera Genics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vera Genics Ltd filed Critical Vera Genics Ltd
Publication of AU2543301A publication Critical patent/AU2543301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90241—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU25433/01A 2000-01-14 2001-01-12 Method and kit for diagnosis of neoplastic transformation Abandoned AU2543301A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17614700P 2000-01-14 2000-01-14
US60176147 2000-01-14
US50235500A 2000-02-11 2000-02-11
US09502355 2000-02-11
PCT/IB2001/000088 WO2001051660A2 (en) 2000-01-14 2001-01-12 Method and kit for diagnosis of neoplastic transformation

Publications (1)

Publication Number Publication Date
AU2543301A true AU2543301A (en) 2001-07-24

Family

ID=26871924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25433/01A Abandoned AU2543301A (en) 2000-01-14 2001-01-12 Method and kit for diagnosis of neoplastic transformation

Country Status (2)

Country Link
AU (1) AU2543301A (en)
WO (1) WO2001051660A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10001491B2 (en) * 2013-03-28 2018-06-19 Centre Hospitalier Universitaire De Montpellier Method for determining radiosensitivity
CN106290866A (en) * 2016-08-16 2017-01-04 海南大学 The indirect ELISA detection method of bovine papilloma virus 13 type antibody
CN111876528A (en) * 2020-08-13 2020-11-03 海南大学 PCR kit of bovine papilloma virus oncogene E5 and establishment method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037235A1 (en) * 1997-02-24 1998-08-27 Cornell Research Foundation, Inc. Method of screening agents as candidates for drugs or sources of drugs
FI971124A0 (en) * 1997-03-18 1997-03-18 Locus Genex Oy Method Foer diagnosis av magcancer

Also Published As

Publication number Publication date
WO2001051660A3 (en) 2002-03-14
WO2001051660A2 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
IL153824A0 (en) Method and kit for diagnosis of diseases
AU2001252973A1 (en) Biosensor and related method
EP1157707B8 (en) Method and composition for deforming soft tissues
AU6214800A (en) Exercise kit and method of using same
AU2002324775A1 (en) Architecture tool and methods of use
AU2001270943A1 (en) Surgical instrument and method of using the same
AU2001288249A1 (en) Biosensors and methods for their use
AU2001269825A1 (en) Suturing method and apparatus
AU2001271530A1 (en) Method of hard tissue repair
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2745000A (en) Method for nucleic acid isolation and kit
AU2001255199A1 (en) Ceramide derivatives and method of use
AU2002211736A1 (en) Methods for synthesizing precipitated silica and use thereof
AU2001286983A1 (en) Method of treatment
AU4819899A (en) Coupling half and method of making same
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2002324895A1 (en) Cosmetic kit and method
AU2002315225A1 (en) Fastener remover and method of use
AU6213200A (en) Exchanger apparatus and method of manufacture
AU2001236718A1 (en) Bioreactor and related method
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2001280646A1 (en) Display and method of manufacture
AU2002210968A1 (en) Method of introducing amino group and method of synthesizing amino acid
AU2543301A (en) Method and kit for diagnosis of neoplastic transformation
AU2001262177A1 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase